| # | Drug | Count |
|---|---|---|
| 0 | IBRUTINIB | 38 |
| 1 | RITUXIMAB | 31 |
| 2 | VENETOCLAX | 21 |
| 3 | CYCLOPHOSPHAMIDE | 20 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 20 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 20 |
| 6 | FLUDARABINE PHOSPHATE | 20 |
| 7 | IDELALISIB | 15 |
| 8 | DOXORUBICIN | 12 |
| 9 | PREDNISONE | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLORAMBUCIL | 9 | 0.0023 |
| 1 | IDELALISIB | 15 | 0.0021 |
| 2 | PIRTOBRUTINIB | 2 | 0.0020 |
| 3 | FLUDARABINE PHOSPHATE | 20 | 0.0005 |
| 4 | IBRUTINIB | 38 | 0.0005 |
| 5 | GRANULOCYTE COLONY STIMULATING FACTOR | 1 | 0.0005 |
| 6 | BENDAMUSTINE HCL | 7 | 0.0004 |
| 7 | ALEMTUZUMAB | 7 | 0.0004 |
| 8 | FAMCICLOVIR | 1 | 0.0004 |
| 9 | OBINUTUZUMAB | 6 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 7 | 0.0004 |
| 1 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 2 | BCL-2 Inhibitor [EPC] | 21 | 0.0003 |
| 3 | Thrombopoietin Receptor Agonist [EPC] | 2 | 0.0001 |
| 4 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 32 | 0.0001 |
| 6 | Alkylating Drug [EPC] | 22 | 0.0001 |
| 7 | Kinase Inhibitor [EPC] | 40 | 0.0001 |
| 8 | Iron Chelator [EPC] | 2 | 0.0001 |
| 9 | Non-narcotic Antitussive [EPC] | 1 | 0.0001 |